Physician

Khavar J Dar, MD

According to 2025 Medicare claims, Khavar Dar, MD (NPI: 1669449617) practices pulmonary disease in the Odessa, TX market, with the plurality of this provider's patient population coming from Ector, TX. This provider's primary affiliated billing organization is ODESSA MEDICAL ENTERPRISES PLLC (NPI: 1992986053; TIN: 392065503) and primary practice location at 79761-9998. Dar is affiliated with the CareMax Accountable Care Network, LLC (ACO ID: A5080), participating under the MSSP model.

Dar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 304 traditional Medicare patients, billed 1,946 HCPCS/CPT codes, and received $159,166 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 5,106 prescription claims across 341 beneficiaries totaling $1,119,815 in drug costs, led by Ofev (Nintedanib Esylate). DME data shows 1,151 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $174,548 and ending at $159,166. Concurrently, Part D prescription costs have changed little. For DME billing, reported payments rose steadily, from $94,597 to $101,921.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	603	4,344	$174,548
2016	580	3,269	$162,669
2017	637	3,000	$188,699
2018	619	3,741	$277,093
2019	597	3,309	$237,663
2020	608	3,837	$308,769
2021	444	2,595	$192,935
2022	359	1,579	$117,916
2023	346	2,144	$176,823
2024	304	1,946	$159,166

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	424	10,415	$866,935
2016	394	10,134	$807,595
2017	403	9,311	$786,945
2018	379	8,545	$924,683
2019	416	8,330	$963,498
2020	390	8,141	$959,037
2021	359	6,753	$867,419
2022	341	5,719	$846,846
2023	340	5,483	$1,021,796
2024	341	5,106	$1,119,815

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	267	1,536	$104,417
2016	249	1,375	$80,073
2017	184	1,251	$71,156
2018	218	1,542	$85,716
2019	209	1,330	$74,440
2020	161	1,270	$77,758
2021	120	1,418	$96,503
2022	73	1,029	$92,688
2023	110	1,215	$121,195
2024	122	1,151	$109,125

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	52	53	$121
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	65	65	$117
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	110	170	$87
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	61	1,154	$85
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	168	398	$57

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ofev	Nintedanib Esylate	27	810	$347,390
Prolastin C	Alpha-1-Proteinase Inhibitor	12	336	$150,511
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	152	5,190	$109,224
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	97	4,140	$84,616
Trulicity	Dulaglutide	54	1,848	$61,760

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0465	Home ventilator, any type, used with invasive interface, (e.g., tracheostomy tube)	Y	N/R	31	$31,049
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	37	285	$23,568
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	16	$16,149
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	12	$5,309
E1392	Portable oxygen concentrator, rental	Y	18	113	$3,993

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Khavar J. Dar, MD?

Tedicare shows public-source Medicare data for Khavar J. Dar, MD (NPI 1669449617), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Khavar J. Dar, MD have ACO affiliation data?

Khavar J. Dar, MD is shown with ACO affiliation data for CareMax Accountable Care Network, LLC (MSSP, ACO ID A5080).

What billing organization is linked to Khavar J. Dar, MD?

Khavar J. Dar, MD is linked to ODESSA MEDICAL ENTERPRISES PLLC (billing NPI 1992986053) in the available physician profile data.

Does Khavar J. Dar, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.